PQ401 hydrochloride

CAS No. ——

PQ401 hydrochloride( —— )

Catalog No. M19402 CAS No. ——

PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 Get Quote
5MG 74 Get Quote
10MG 104 Get Quote
25MG 184 Get Quote
50MG 331 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PQ401 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.
  • Description
    PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    IGF-1R
  • Recptor
    IGF-1R
  • Research Area
    Cancer
  • Indication
    Cancer

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    378.25
  • Molecular Formula
    C18H17Cl2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    Cl.COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gable KLetal Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol Cancer Ther. 2006 Apr;5(4):1079-86.
molnova catalog
related products
  • HNMPA

    HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.

  • IGF-I 24-41

    IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).

  • Tyrphostin AG 538

    Tyrphostin AG 538 is a chalcone compound, an IGF-1 receptor kinase inhibitor (IC?0 : for 400 nM) that is potent, cell-permeable, reversible, and competitive.